KYNB is Kyntra Bio, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $8.53. Market cap: $32M.
Stock snapshot
| Price | $8.53 |
| Market cap | $32M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About KYNB
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Related non-dividend companies
Other non-dividend stocks investors research alongside KYNB. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is KYNB's current stock price?
KYNB (Kyntra Bio, Inc.) is currently trading at $8.53.
Does KYNB pay a dividend?
KYNB (Kyntra Bio, Inc.) does not currently pay a regular dividend.
Track KYNB in DiviDrip
Add KYNB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search KYNB and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.